OncoSeer Diagnostics, Inc.

OncoSeer Diagnostics, Inc. (OncoSeer), a collaboration with UT Southwestern Medical Center (UTSW), is developing multimarker blood tests that diagnose and predict immune related adverse events (irAE) in oncology patients undergoing immune checkpoint inhibitor (ICI) therapy.

Mission & Core Values

At OncoSeer Diagnostics, Inc. we’re committed to creating a healthier world for everyone – no matter the challenges ahead of us. For more than seven years, we have tirelessly researched immunotherapy toxicities – including how to predict, monitor and treat them. Through consistent and transformative research, we are driving innovation that has the potential to treat patients more safely and effectively with cancer immunotherapy.

Vision

OncoSeer is dedicated to empowering patients and clinicians  with knowledge to guide cancer immunotherapy

Mission

OncoSeer will enable oncologists to provide the most effective and safest treatment of patients with cancer by researching, developing and providing new diagnostic and predictive tests

Core Values

Integrity

Doing What’s Right

Inclusion

Encouraging Diversity

Teamwork

Working Together to Strengthen Results

Accountability

Taking Personal Responsibility

Tenacity

Not accepting failure
as an end result

Excellence

Performing smarter
research to drive future success

Integrity

Doing What’s Right

Inclusion

Encouraging Diversity

Teamwork

Working Together to Strengthen Results

Accountability

Taking Personal Responsibility

Tenacity

Don’t accept failure as an end result

Excellence

Smarter research leads to future success

Management Team

Jeff Stone

Co-Founder & CEO, Board Member

David Gerber MD

Co-Founder & Chief Medical Officer

Jason Park MD, PhD

Co-Founder & Chief Laboratory Officer

Lindsay Cowell MS, PhD

Chief Scientific Officer

Danny Tobey MD, JD

Co-Founder, Board Member

Doug Foster

Commercial Advisor

Board of Directors

Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

Lorem Ipsum has been the industry’s standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

Scientific Advisors

Robert Anders MD, PhD

Ward Wakeland PHD

Scott Waldman MD, PHD

Yang Xie PHD